Trials / Terminated
TerminatedNCT00001788
Genetic Basis of Primary Immunodeficiencies
Molecular Basis of Primary Immunodeficiencies
- Status
- Terminated
- Phase
- —
- Study type
- Observational
- Enrollment
- 119 (actual)
- Sponsor
- National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS) · NIH
- Sex
- All
- Age
- —
- Healthy volunteers
- Not accepted
Summary
The purpose of this study is to evaluate patients with primary immunodeficiency disorders to identify patients with mutations of the genes for the following proteins: Jak3, STAT1, STAT4, interleukin-7, interleukin-7 receptor, interleukin-12 receptor subunits, and others. Patients will undergo screening history, physical examination, and clinical laboratory evaluation at referring institutions and tissue samples, or cell lines will be sent to the NIH. We will establish cell lines if necessary, prepare DNA and RNA for molecular genetic analysis and study cytokine signal transduction in patient cell lines.
Detailed description
The purpose of this study is to evaluate patients with primary immunodeficiency disorders to identify patients with mutations of the genes for the following proteins: Jak3, STAT1, STAT4, interleukin-7, interleukin-7 receptor, interleukin-12 receptor subunits, and others. Patients will undergo screening history, physical examination, and clinical laboratory evaluation at referring institutions and tissue samples, or cell lines will be sent to the NIH. We will establish cell lines if necessary, prepare DNA and RNA for molecular genetic analysis and study cytokine signal transduction in patient cell lines.
Conditions
Timeline
- Start date
- 2011-08-21
- Primary completion
- 2019-07-02
- Completion
- 2020-07-16
- First posted
- 1999-11-04
- Last updated
- 2021-05-27
Locations
1 site across 1 country: United States
Source: ClinicalTrials.gov record NCT00001788. Inclusion in this directory is not an endorsement.